129 filings
8-K
ITCI
Intra-Cellular Therapies Inc
7 May 24
Intra-cellular Therapies Reports First Quarter 2024 Financial Results
7:40am
8-K
ITCI
Intra-Cellular Therapies Inc
24 Apr 24
Other Events
4:20pm
8-K
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:40pm
8-K
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints
7:10am
8-K
h54 g6wrkzyrw4
1 Apr 24
Other Events
5:15pm
8-K
8mlowvb3bwd9q6h
19 Mar 24
Intra-cellular Therapies Announces Executive Appointments and Leadership Changes
8:44am
8-K
g1p0 1yur9h2fkn4yv
22 Feb 24
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Corporate Update
7:39am
8-K
hnxuolo3sh7e
2 Nov 23
Intra-cellular Therapies Reports Third Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
8:01am
8-K
8og5rla4 8eu
3 Aug 23
Intra-cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 Caplyta Sales Guidance
7:39am
8-K
hdo46 mee18q7s
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
694vgfw87mkl fz
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
8-K
5yh9v wnosdllhil4
28 Mar 23
Other Events
7:12am
8-K
dwddah9uwxtnqay
1 Mar 23
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2022 Financial Results and Provides Corporate Update
7:41am
8-K
uta6dhde7 5mqg5dtuz
9 Jan 23
Entry into a Material Definitive Agreement
5:13pm
8-K
b16c0p2i2xln5lrzj
22 Dec 22
Entry into a Material Definitive Agreement
4:09pm
8-K
tjb lc8pz
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
pyn67l8uw
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
3jrk3ubr42do8t0 0y
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
gict euaphwvxy13b
10 May 22
Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:37am